ICCC Immucell Corp.

649
Loading...
Loading...
News
all
press releases
FONAR's Stock Advances 5% in Three Months: Key Trends Ahead
FONR leverages hybrid MRI tech and a strong balance sheet to navigate industry headwinds, though rising costs and regulatory risks tied to claim collections remain key challenges.
Zacks·28d ago
News Placeholder
More News
News Placeholder
ImmuCell Swings to Q2 Profit on Strong Sales, Shares Still Slide
ICCC posts Q2 profit on higher sales and margins, but shares fall as investors weigh one-time boosts and Re-Tain's delayed commercialization.
Zacks·2mo ago
News Placeholder
ImmuCell Upgraded to Outperform on Sales Surge & FDA Upside
ICCC earns "Outperform" rating with record Q1 sales, margin gains and growth potential tied to Re-Tain's FDA progress and new product formats.
Zacks·3mo ago
News Placeholder
The Zacks Analyst Blog Highlights Alphabet, Oracle, Shell, Fossil and ImmuCell
GOOGL, ORCL, and SHEL show sector strength, while microcaps FOSL and ICCC surge on strategic shifts and rising profitability.
Zacks·3mo ago
News Placeholder
Top Research Reports for Alphabet, Oracle & Shell
GOOGL, ORCL, and SHEL stand out with strong cloud, AI, and LNG tailwinds, despite macro and margin headwinds.
Zacks·3mo ago
News Placeholder
ImmuCell Reports Y/Y Q1 Earnings Growth on Record Sales & Margin Gains
Zacks·5mo ago
News Placeholder
12 titres de soins de sant en mouvement lors de la session apr s-cl ture le 09/04/2024
Gagnants Le titre IN8bio (NASDAQ:INAB) a augment mardi de 31,19% 1,43 dollars lors de la session after-market. L'action ImmuCell (NASDAQ:ICCC) a grimp de 11,11% 5,80 dollars. L'action aTyr...
Benzinga·1y ago
News Placeholder
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
PORTLAND, Maine, Feb. 27, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ( ImmuCell or the Company ), a growing animal health company that develops, manufactures and markets...
Globe Newswire·2y ago
News Placeholder
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
Conference Call Scheduled for Wednesday, February 28, 2024 at 9:00 AM ETPORTLAND, Maine, Feb. 16, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ( ImmuCell or the Company ), a...
Globe Newswire·2y ago
News Placeholder
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023
PORTLAND, Maine, Jan. 08, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ( ImmuCell or the Company ), a growing animal health company that develops, manufactures and markets...
Globe Newswire·2y ago

Latest ICCC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.